2020 annual financial data
Propanc Biopharma 2020 Operating cash flow margin
Direct answer
Operating cash flow margin was Not calculable.
Operating income was -3,494,000 USD and net income was -4,741,000 USD.
Operating cash flow was -1,849,589 USD.
Get free Propanc Biopharma email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -3,494,000 USD
- Net income
- -4,741,000 USD
- Operating cash flow
- -1,849,589 USD